GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » Kinarus Therapeutics Holding AG (XSWX:KNRS) » Definitions » Median PS Value

Kinarus Therapeutics Holding AG (XSWX:KNRS) Median PS Value : CHF0.00 (As of Jun. 19, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Kinarus Therapeutics Holding AG Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Kinarus Therapeutics Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF0. Kinarus Therapeutics Holding AG's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is CHF0.00.

As of today (2024-06-19), Kinarus Therapeutics Holding AG's share price is CHF0.0262. Kinarus Therapeutics Holding AG's Median PS Value is CHF0.00. Therefore, Kinarus Therapeutics Holding AG's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Kinarus Therapeutics Holding AG's Median PS Value or its related term are showing as below:

XSWX:KNRS's Price-to-Median-PS-Value is not ranked *
in the Transportation industry.
Industry Median: 0.97
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Kinarus Therapeutics Holding AG Median PS Value Historical Data

The historical data trend for Kinarus Therapeutics Holding AG's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kinarus Therapeutics Holding AG Median PS Value Chart

Kinarus Therapeutics Holding AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.06 0.05 0.01 -

Kinarus Therapeutics Holding AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 - 0.01 - -

Competitive Comparison of Kinarus Therapeutics Holding AG's Median PS Value

For the Airports & Air Services subindustry, Kinarus Therapeutics Holding AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kinarus Therapeutics Holding AG's Price-to-Median-PS-Value Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, Kinarus Therapeutics Holding AG's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Kinarus Therapeutics Holding AG's Price-to-Median-PS-Value falls into.



Kinarus Therapeutics Holding AG Median PS Value Calculation

Kinarus Therapeutics Holding AG's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0*
=0.00

10-Year Median PS Ratio is .
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kinarus Therapeutics Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2021 was CHF0.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kinarus Therapeutics Holding AG  (XSWX:KNRS) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Kinarus Therapeutics Holding AG's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.0262/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kinarus Therapeutics Holding AG Median PS Value Related Terms

Thank you for viewing the detailed overview of Kinarus Therapeutics Holding AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Kinarus Therapeutics Holding AG (XSWX:KNRS) Business Description

Traded in Other Exchanges
N/A
Address
3, Avenue de Florimont, Lausanne, CHE, CH-1006
Perfect Holding SA is a Switzerland-based company that focuses on the acquisition and management of investments in companies, which are active in the aircraft management and related services sector. The company operates in one business segment which includes Charters. The products provided by the company include Aircraft sales, Charter sales, and Aircraft consultancy.

Kinarus Therapeutics Holding AG (XSWX:KNRS) Headlines

No Headlines